H.B. Fuller (NYSE:FUL – Get Rating) had its price objective dropped by equities research analysts at Robert W. Baird from $85.00 to $80.00 in a report issued on Friday, The Fly reports. The firm presently has an "outperform" rating on the specialty chemicals company's stock. Robert W. Baird's price objective points to a potential upside of 16.19% from the company's previous close.
Separately, StockNews.com assumed coverage on H.B. Fuller in a report on Wednesday, October 12th. They issued a "hold" rating on the stock. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, H.B. Fuller has a consensus rating of "Hold" and a consensus price target of $71.25.
Get H.B. Fuller alerts:H.B. Fuller Price Performance
NYSE FUL opened at $68.85 on Friday. H.B. Fuller has a 1-year low of $57.36 and a 1-year high of $81.41. The business's fifty day moving average price is $75.23 and its 200-day moving average price is $68.58. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of 19.29 and a beta of 1.54. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.93 and a quick ratio of 1.18.
Insider Activity
In other news, CEO James Owens sold 79,061 shares of the business's stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $71.07, for a total value of $5,618,865.27. Following the transaction, the chief executive officer now directly owns 163,703 shares in the company, valued at $11,634,372.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, VP Timothy J. Keenan sold 9,154 shares of the business's stock in a transaction dated Monday, October 31st. The stock was sold at an average price of $69.92, for a total value of $640,047.68. Following the sale, the vice president now directly owns 22,871 shares in the company, valued at $1,599,140.32. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO James Owens sold 79,061 shares of the business's stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $71.07, for a total value of $5,618,865.27. Following the completion of the sale, the chief executive officer now owns 163,703 shares in the company, valued at $11,634,372.21. The disclosure for this sale can be found here. Insiders have sold 200,357 shares of company stock worth $14,707,214 over the last ninety days. Corporate insiders own 4.69% of the company's stock.Institutional Investors Weigh In On H.B. Fuller
Several large investors have recently added to or reduced their stakes in the stock. Wesbanco Bank Inc. bought a new stake in H.B. Fuller during the fourth quarter worth approximately $365,000. Bank of New York Mellon Corp grew its stake in shares of H.B. Fuller by 2.8% during the third quarter. Bank of New York Mellon Corp now owns 617,129 shares of the specialty chemicals company's stock valued at $37,090,000 after buying an additional 17,027 shares during the last quarter. Teachers Retirement System of The State of Kentucky bought a new position in shares of H.B. Fuller during the third quarter valued at approximately $996,000. Alpha Paradigm Partners LLC bought a new position in shares of H.B. Fuller during the third quarter valued at approximately $992,000. Finally, BNP Paribas Arbitrage SNC grew its stake in shares of H.B. Fuller by 105.8% during the third quarter. BNP Paribas Arbitrage SNC now owns 32,200 shares of the specialty chemicals company's stock valued at $1,935,000 after buying an additional 16,553 shares during the last quarter. 96.53% of the stock is owned by institutional investors.
About H.B. Fuller
(Get Rating)
H.B. Fuller Co engages in the manufacture and marketing of adhesives, sealants, and other specialty chemical products. It operates through the following segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts and envelope markets.
Read More
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- MarketBeat Week in Review – 1/16 – 1/20
- Does Old Dominion Show That Trucking Is Hitting The Brakes?
- Nordstrom Puts Fear Of Markdowns Into Retail Sector
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving '23 Growth
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.